Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - PRE-TAX INCOME
Pre-tax Income SMMT - Summit Therapeutics Inc.
-616 M
LAST VALUE
-163.65%
2 YEAR CAGR
-148.28%
5 YEAR CAGR
-49.49%
10 YEAR CAGR